Low-macrophage-adhesion/activation culture devices and methods thereof for continuous hematopoiesis and expansion of hematopoietic stem cells

• US 20200131462A1
• Filed: 08/28/2019
• Published: 04/30/2020
• Est. Priority Date: 10/28/2018
• Status: Abandoned Application

• Current Assignee: Schickwann Tsai
• Original Assignee: Schickwann Tsai
• Inventors: Tsai, Schickwann
• Application Number:
  US16/554,257
• Publication Number:
  US 20200131462A1
• Time in Patent Office: Days
• CPC Class Codes: C12M 23/10 Petri dish crystallising dishes B01L3/06
• CPC Class Codes: C12M 23/12 Well or multiwell plates C12M25/04 takes precedence
• CPC Class Codes: C12M 23/20 Material Coatings immunocoatings C12M25/00
• CPC Class Codes: C12M 23/34 Internal compartments or partitions
• CPC Class Codes: C12M 25/04 in combination with well or multiwell plates, i.e. culture inserts
• CPC Class Codes: C12N 2500/30 Organic components
• CPC Class Codes: C12N 2501/125 Stem cell factor [SCF], c-kit ligand [KL]
• CPC Class Codes: C12N 2501/145 Thrombopoietin [TPO]
• CPC Class Codes: C12N 2501/39 Steroid hormones
• CPC Class Codes: C12N 2533/30 Synthetic polymers
• CPC Class Codes: C12N 5/0068 General culture methods using substrates for specific animal cell type C12N5/06
• CPC Class Codes: C12N 5/0647 Haematopoietic stem cells; Uncommitted or multipotent progenitors

Abstract

Hematopoietic stem cells are extremely difficult to maintain or expand in vitro. Two observations in traditional long-term bone marrow cultures strongly suggest that macrophages may be at the root of the problem: First, micromolar concentrations of hydrocortisone improve the longevity of long-term bone marrow cultures and hydrocortisone is known as a potent inhibitor of macrophage production of pro-inflammatory cytokines, chemokines, enzymes, nitrogen oxide and reactive oxygen species and redirects macrophages to the anti-inflammatory differentiation pathway; Second, the decline of hematopoiesis in long-term bone marrow cultures coincides with the development of large numbers of adherent and non-adherent macrophages including foreign body giant cells. These adherent macrophages and foreign body giant cells exhibit well-spread morphology, contain numerous lysosomes and phagolysosomes in the cytoplasm and are metabolically active. We hypothesize that hydrocortisone fails to suppress all aspects of macrophage pro-inflammatory activation/differentiation, resulting in the production of inhibitors or toxins of hematopoiesis. Macrophage adhesion in cell culture depends on serum proteins pre-adsorbed to the tissue-culture-treated polystyrene (TC-PS), which adsorbs proteins via mostly hydrophilic interactions. TC-PS is used in almost all tissue culture devices currently available. Cellular adhesion provides a strong stimulus for metabolic, mitotic and certain gene activities. Therefore, we seek to reduce macrophage adhesion and activation by culturing bone marrow cells in tissue culture devices composed of or covered with polymers with very different protein-binding characteristics than TC-PS such as polyethylene (PE) and other polyolefins, the latter bind proteins via exclusively hydrophobic interactions. As a result, polyolefins bind different proteins and in lower quantities than TC-PS. Furthermore, PE does not contain additional chemical features like the phenolic rings of polystyrene that might contribute to protein binding and macrophage adhesion/activation. Using these new culture devices, we developed a drastically different long-term bone marrow culture, the “Low Macrophage-Adhesion/Activation” (LoMAC) bone marrow culture. In LoMAC bone marrow culture, hematopoiesis continues for months to over a year and hematopoietic stem cells are amplified gradually. In stark contrast to traditional long-term bone marrow cultures, de novo erythropoiesis and megakaryocytopoiesis proceed robustly in the LoMAC bone marrow culture and B-lymphocyte and natural killer cell progenitors can be continuously derived. Thus, these new culture devices and the associated LoMAC culture method offer a new way to study hematopoiesis in vitro and provide a more robust platform for the expansion of hematopoietic stem cells and progenitors ex vivo.

Claims

1. A cell culture device fabricated from materials with a substantially lower capacity to bind macrophages and stimulate inflammatory activity than polystyrene or tissue culture-treated polystyrene.

2. The device in claim 1 that is fabricated from low-density polyethylene.

3. The device in claim 1 that is fabricated from poly(4-methyl-1-pentene).

4. The device in claim 1 that is fabricated from polyolefins other than low-density polyethylene and poly(4-methyl-1-pentene).

5. A device in claims 1-4 with a super-deep dish feature wherein the ratio of dish height to bottom diameter is greater than 0.2 so that substantially more culture medium can be added and cells at the bottom will not be disturbed during medium exchange.

14. A method for cultivating hematopoietic stem cells and progenitors using a device in claims 1-13 whereby:

a) hematopoietic cells are added to a suitable volume of culture medium at a cell density between one cell and five million cells per milliliter of culture medium;

b) add an effective amount of hydrocortisone to suppress pro-inflammatory macrophage activation and effective amounts of c-kit ligand and thrombopoietin plus additional substances necessary for the survival and proliferation of hematopoietic stem and progenitor cells;

c) transfer the cell/medium mixture to a culture device in claims 1-13;

d) incubate the cell/medium mixture and the culture device in a tissue culture incubator with suitable concentrations of air, carbon dioxide, humidity and a suitable temperature for one day to twelve months;

e) replace one half to one quarter of spent culture medium with fresh medium every 1 to 3 days with minimal disturbance to the cells at the bottom;

f) subculture cells at a 1;

2 subculturing ratio every 5 or more days or when cells are overcrowded;

g) avoid unnecessary manipulation of the culture.

6. A cell culture device in which all internal surfaces that may come in contact with cells are covered with a layer of materials with a substantially lower capacity to bind macrophages and stimulate inflammatory activity than polystyrene or tissue culture-treated polystyrene.

7. The device in claim 6 in which the internal surfaces are covered with a layer of low-density polyethylene.

8. The device in claim 6 in which the internal surfaces are covered with a layer of poly(4-methyl-1-pentene).

9. The device in claim 6 in which the internal surfaces are covered with a layer of polyolefins other than low-density polyethylene and poly(4-methyl-1-pentene).

10. A removable cell culture insert in which the bottom and sidewalls are made of materials with a substantially lower capacity to bind macrophages and stimulate inflammatory activity than polystyrene or tissue culture-treated polystyrene.

11. The insert in claim 10 in which the bottom and sidewalls are made of low-density polyethylene.

12. The insert in claim 10 in which the bottom and sidewalls are made of poly(4-methyl-1-pentene).

13. The insert in claim 10 in which the bottom and sidewalls are made of polyolefins other than low-density polyethylene and poly(4-methyl-1-pentene).